Articles On Hera Med (ASX:HMD)

Title Source Codes Date
April Winners Column: Resources re-takes the mantle, led by one stock that gained nearly 500pc

Google April 2021 and the first things you’ll find isn’t ASX winners but questions about COVID-19. Just another month in the pandemic, right? Well, yes and no. On one hand the vaccine race continues across the world – far slower than we’d l...

Stockhead HMD 1 day ago
Telemedicine witnesses a boom amid COVID-19: A look at 3 ASX stocks  

Summary With the current emergency, it is anticipated that telehealth or telemedicine could be the future of medicine. COVID-19 pandemic resulted in considerable adoption of telehealth solutions, mainly to avoid physical contact. The...

Kalkine Media HMD 1 week ago
HeraMED secures landmark commercial agreement with Joondalup Health Campus

HeraMED has announced a paid pilot with a leading medical provider for 100 expectant mothers. HeraMED’s (ASX:HMD) HeraCARE platform will be rolled out to 100 expectant mothers at WA’s Joondalup Health Campus as part of a landmark paid pilo...

Stockhead HMD 2 weeks ago
Last Orders: ASX slides again – falls below 7,000 mark

The ASX fell again today, as risk-on sentiment continued to reign supreme in the markets. The ASX 200 fell 0.29 per cent, a smaller drop then yesterday but one that saw it close below 7,000 – at 6,997. Small caps fell by more, with the ASX...

Stockhead HMD 2 weeks ago
Last Orders: ASX ends 5 day winning streak but still above 7,000

The ASX 200 has finished the day in the red but is still above 7,000 points. The ASX 200 shed 0.68 per cent closing at 7,018 points while the ASX Emerging Companied Index fell 0.33 per cent, closing at 2,101 points. All sectors were in the...

Stockhead HMD 2 weeks ago
Leading scientific publication backs HeraMED’s foetal heartbeat monitor

The official publication of the American College of Obstetricians and Gynecologists has endorsed the results of a clinical trial into HeraMED’s foetal monitoring device. HeraMED (ASX:HMD) is a step closer to commercialisation following the...

Stockhead HMD 1 month ago
A Glance at the Financial Performance of HeraMED and Adherium

Source:New Africa ,Shutterstock Summary COVID-19 had a significant impact on the HeraMED’s and Adherium’s first half 2021 results. However, the two players made critical developments during the period. HeraMED plans to expand further...

Kalkine Media HMD 2 months ago
5 ASX penny stocks in healthcare space

Summary With COVID-19 giving the opportunity to develop products, enhance services and conduct R&D, healthcare sector will be vigilantly gauged. Early spotting of a winning penny stock can offer considerable rewards to patient and...

Kalkine Media HMD 2 months ago
How did 1H FY21 turn out for Global Health (ASX:GLH)?

Summary Amid growing adoption of digital platforms, Global Health registered a robust half-year performance. Total customer revenue for the period was up by 20% on PCP. The MasterCare platform for community health care providers exper...

Kalkine Media HMD 2 months ago
Global Health (ASX: GLH): Lifecard Patient Portal demand magnifies

Summary Global Health Ltd (ASX:GLH) said Lifecard Patient Portal is seeing high demand as health delivery organisations have embraced digital engagement with patients. Lifecard Patient Portal assists consumers and doctors in managing d...

Kalkine Media HMD 4 months ago
Why HeraMed (ASX:HMD) and Dimerix (ASX:DXB) are trending?

Summary HeraMED’s partnership with eCare21 aims to fast-track awareness of HeraCARE and HeraBEAT across the US. Dimerix drug compound DMX-200 is set to be tested for COVID-19-induced ARDS in the global study. Dimerix is confident that...

Kalkine Media HMD 5 months ago
HeraMED teams up with eCare21 to deliver smart solution for in-home maternity care to US patients

Maternity-focused technology start-up HeraMED (ASX: HMD) has signed an agreement with US virtual care provider eCare21 to integrate its smart pregnancy monitoring solutions into eCare21’s software-as-a-service (SaaS) platform. Under the agr...

SmallCaps HMD 7 months ago
New investors back HeraMed’s latest raise to the tune of $2.3m

Special Report: Maternity health digitiser HeraMED has raised serious cash from new and existing sophisticated and institutional investors to speed the rollout of its software platform HeraCARE. HeraMED (ASX:HMD) has raised $2.32m to speed...

Stockhead HMD 11 months ago
HeraMED gets set for Aussie clinical trials with new deal

Special Report: Maternal health tech company HeraMED is preparing for clinical trials in Australia with a new partnership. HeraMED (ASX:HMD) is getting ready to run clinical trials for its maternity care telehealth and remote monitoring so...

Stockhead HMD 11 months ago
HeraMED ramps up Australian strategy with new distribution deal

Special Report: Medical tech company HeraMED has signed an exclusive deal to distribute its foetal heart rate monitors in Australia. HeraMED (ASX:HMD) is accelerating its commercialisation strategy with an exclusive two-year Australian dist...

Stockhead HMD 11 months ago
VidCon Recap: Here are the most important things we learned about the future of telehealth

As we approach the middle of 2020, the investment environment surrounding the fallout from the COVID-19 pandemic remains complex. Along with threats, there will be plenty of opportunities. And it’s against that backdrop that this week marke...

Stockhead HMD 1 year ago
Stockhead VidCon: The Future of TeleHealth

VidCon is Stockhead’s new virtual conference series, bringing you expert insights, panel discussions and presentations on the most interesting and relevant investment sectors from leading analysts, listed small caps and industry participant...

Stockhead HMD 1 year ago
StockDoc Podcast: HeraMED’s telehealth offering for pregnant women is booming under COVID-19

Seasoned financial advisor, investment manager and corporate director Dr Nigel Finch is back in the radio booth for another instalment of The StockDoc Podcast. In this episode the good doctor sits down with Alexander Radke, general manager...

Stockhead HMD 1 year ago
Stock Talk: TeleHealth in a COVID-19 world and beyond

Stock Talk is a new Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this first edition, host Dr Nigel Finch examines the coronavirus-induced boom of the telehealth industry. Populatin...

Stockhead HMD 1 year ago
HeraMED in ‘advanced discussions’ for roll-out of telehealth maternity software as COVID-19 rampages

Maternity telehealth company HeraMED (ASX: HMD) revealed this morning in a conference call it was in “advanced discussions” regarding the expedited commercial roll-out of its platform across the US, UK, Australia and Israel. The company’s H...

SmallCaps HMD 1 year ago
HeraMed’s telehealth solutions address self-isolation needs

HeraMED Limited (ASX:HMD), a medical technology company leading the digital transformation of maternity care with its proprietary in-home maternity care platform, advised on Tuesday morning that it had received a significant uplift in inter...

FinFeed HMD 1 year ago
Remote control: 5 medtechs set to benefit from the surge in demand for tele-health solutions

The coronavirus-induced market carnage of the last few weeks has rattled plenty of investor nerves. But as with any major correction, some industries feel the brunt of the impact while for others, the dramatic shift presents an opportunity....

Stockhead HMD 1 year ago
HeraMED’s hybrid maternity care platform poised for market testing

Special Report: HeraMed’s fast-tracked development process has paid dividends as its flagship product nears pilot testing. Medical technology company HeraMED’s (ASX:HMD) proprietary hybrid maternity care platform, HeraCARE, is now fully fu...

Stockhead HMD 1 year ago
Health: Compumedics wins FDA approval for its brain scanners, leaps 20pc

Another ASX small cap has won the blessing of the Food and Drug Administration (FDA) for its products enter the US market. This morning it was Compumedics (ASX:CMP). Its signature product, the Orion LifeSpan Magnetoencephalography single De...

Stockhead HMD 1 year ago
HeraMED (ASX:HMD) appoints General Manager to support U.S. market entry

HeraMED (HMD) has appointed Alexander Radke as General Manager of its U.S. operations Alexander has previously held senior roles and has vast experience in the U.S. healthcare market He will use his expertise to develop the company’s strat...

themarketherald.com.au HMD 1 year ago
HMD Set to Create One of the World’s Most Advanced AI-Based Pregnancy Monitoring Diagnostic Tools

2020 could be the year HeraMED (ASX:HMD) comes of age and it all has to do with its Artificial Intelligence (AI) platform, a cloud based machine learning software-as-a-service (SaaS) platform, known as OrionAI.

NextTechStock HMD 1 year ago
HeraMED (ASX:HMD) accesses unique pregnancy database to strengthen OrionAI

HeraMED (HMD) has received roughly 90,000 pregnancy monitoring records from the Mayo Clinic via their recent collaboration This is key in progressing the Orion AI platform, a cloud-based platform that analyses pregnancy records and detects...

themarketherald.com.au HMD 1 year ago
Mayo Clinic provides HeraMED with a massive dataset of pregnancy records

Medical technology company, HeraMED Limited (ASX:HMD) has received approximately 90,000 pregnancy records from research and development collaborator the Mayo Clinic, which will be implemented into its OrionAI platform. This provides HeraMED...

FinFeed HMD 1 year ago
Why You Can Expect a Boom in Healthcare Space in 2020: A Glance at 7 Health Care Stocks

Australian health care sector is one of the fastest growing, dynamic and highly diversified sectors having enormous potential to generate substantial returns for the Australian economy. A broad range of companies, from companies engaged in...

Kalkine Media HMD 1 year ago
Artificial Intelligence in Healthcare: Harrison.ai and HeraMED Under Discussion

Technology undoubtedly holds a significant importance in each sector of the industry, more so than ever, and certainly health care sector is no different. Use of technologies in the health care sphere has emerged as a boon for doctors, rese...

Kalkine Media HMD 1 year ago
HeraBEAT users could be in line for full refunds on the cost of the product

Medical technology company, HeraMED Limited (ASX:HMD) is pursuing verification around the potential for its HeraBEAT and HeraCARE solutions to be reimbursed under the US reimbursement code system. Should this occur, under new CPT (Current P...

FinFeed HMD 1 year ago
HeraMED CEO David Groberman talks about the company’s progress

The Mayo Clinic has been established for more than 150 years, and employs more than 4500 physicians and scientists along with 54,000 allied health staff across 19 hospitals in five US states. It has been ranked No 1 hospital in the world fo...

FinFeed HMD 1 year ago
Integration of Health Care with Technology, Looking through 2020s

Technology certainly plays a significant role in each segment of the industry, more so than ever, and health care sector is no different. Introduction of technologies in the health care domain emerged as the biggest blessing not only for pa...

Kalkine Media HMD 1 year ago
HeraMED’s HeraBEAT endorsed by prominent Indian healthcare group

Medical technology group, HeraMED Limited’s (ASX:HMD) distributor based in India has secured a commercial service partnership with Cloudnine Hospital Group to initiate a commercial pilot allowing expecting mothers in the Cloudnine network t...

FinFeed HMD 1 year ago
HeraMed to Spring-Board German Pre Natal Market Entry by Partnering with Telehealth Provider...

HeraMED (ASX:HMD) has signed an agreement with Kinderheldin to add online midwifery service to be offered as HeraBEAT PLUS in Germany.

NextTechStock HMD 1 year ago
HeraMED continues to forge value adding partnerships

The good news keeps flowing for medical technology company, HeraMED Limited (ASX:HMD) with the company announcing today that it has entered into an agreement with leading midwife service provider, Kinderheldin GmbH. This follows news earlie...

FinFeed HMD 1 year ago
Health: HeraMED’s heart rate monitor just got clearance to pop into the US market; it’s now doubled in a week

HeraMED’s (ASX:HMD) foetal ultrasound heart rate monitor has got its long awaited green light to enter the US market and it has doubled in just a few days. The US Food and Drug Administration has approved its 510(k) application meaning it c...

Stockhead HMD 1 year ago
HeraMED receives FDA clearance for HeraBEAT

Medical technology company, HeraMED Limited’s (ASX:HMD) 510(k) application (K191110) for the company’s HeraBEAT US foetal ultrasonic heart rate monitor (HeraBEAT US) has been cleared by the US Food and Drug Administration (FDA). The FDA eva...

FinFeed HMD 1 year ago
HeraMED sets sights on US market after FDA approval for ultrasonic foetal heart rate monitor

Medical data and technology developer HeraMED (ASX: HMD) has been granted key regulatory approval for its foetal ultrasonic heart rate monitor in the US after undergoing a premarket review process for the past 6 months. The US Food and Drug...

SmallCaps HMD 1 year ago
10 at 10: These ASX stocks are shaking things up this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead HMD 1 year ago
Hot Money Monday: These are the most in-demand stocks on the ASX right now

Each Monday, Stockhead recaps which stocks are most heavily in demand by investors — running hot. The analysis is based on the Relative Strength Index (RSI), a technical gauge which measures how trading momentum is affecting the price actio...

Stockhead HMD 1 year ago
HeraMED Transforming the Prenatal Care Via End-to-End Medical Grade Solutions

With a vision to revolutionize the pregnancy ecosystem HeraMED Limited (ASX: HMD) – an innovative medical technology startup, provides smart pregnancy monitoring solutions for home use, against the problems associated with the reliability o...

Kalkine Media HMD 1 year ago
HeraMED shares shot higher, and it may have been due to a ‘$13 billion’ typo

Yesterday was an interesting day on the markets for HeraMED (ASX:HMD), the medtech platform which makes pregnancy-monitoring devices. The stock has been trading in a range between 15c and 17c in recent months. And strategically, it’s been c...

Stockhead HMD 1 year ago
HeraMED’s new age technology addresses age-old problems

Medical technology group HeraMED Limited (ASX:HMD) has gone from strength to strength since listing on the ASX in December 2018, excelling in the area of product development and distribution, but also forging alliances with high profile med...

FinFeed HMD 1 year ago
ASX MedTech Transforming the US$50B Women’s Health Market

HeraMED (ASX:HMD) has a target market of 2 million pregnancies in 2020, 6 million in 2021 and 45 million in 2022.

NextTechStock HMD 1 year ago
Health: Biofilm killer Next Science stays focused on the US market with four new product rollouts

Medical company Next Science (ASX:NXS) reiterated its US market focus in an investor presentation this morning. The company forecast continued revenue growth in the 2020 financial year, led by sales of its non-toxic Xbio formulations which...

Stockhead HMD 1 year ago
Health: Althea highlights local growth potential as major shareholder sells up

Medicinal cannabis stock Althea (ASX:AGH) had a mixed bag of news for investors in its market update this morning. The company said patient numbers for its prescription medicinal cannabis products in Australia are on track to reach 4,000 by...

Stockhead HMD 1 year ago
2 Healthcare Stocks To Look At – HMD, MSB

Australia’s Healthcare Sector is recognised as one the best in the world with significant advances in technology that help provide better ways of delivering healthcare services. However, the sector is also prone to a number of challenges li...

Kalkine Media HMD 1 year ago
The Evolution Of Australia’s Equity Market Over The Past Century

Time is dynamic. Business is dynamic. Change might be the only constant factor but surprisingly for the Aussie share market, some events and statuses have remained intact over the past century. A 100 years is a really long period, and to ha...

Kalkine Media HMD 1 year ago
6 Stocks With Latest Updates- CV1, FZO, ROG, OCC, HMD, IPD

CV Check Ltd CV Check Ltd (ASX: CV1) is a leading online integrated screening and verification company which offers check products to employers, industry associations and individual customers through the CVCheck brand on its proprietary web...

Kalkine Media HMD 1 year ago